The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Covid-19 Small Molecule Drugs Market Research Report 2024
Synopsis
Market Analysis and Insights: Global Covid-19 Small Molecule Drugs Market
The global Covid-19 Small Molecule Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, RdRp accounting for % of the Covid-19 Small Molecule Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Covid-19 Small Molecule Drugs market size is valued at US$ million in 2021, while the North America and Europe Covid-19 Small Molecule Drugs are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Covid-19 Small Molecule Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Covid-19 Small Molecule Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Covid-19 Small Molecule Drugs market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Covid-19 Small Molecule Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Covid-19 Small Molecule Drugs market.
Global Covid-19 Small Molecule Drugs Scope and Market Size
Covid-19 Small Molecule Drugs market is segmented by players, region (country), by Targets and by Application. Players, stakeholders, and other participants in the global Covid-19 Small Molecule Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Targets and by Application for the period 2017-2028.
Segment by Targets
RdRp
3CLpro
Segment by Application
Hospital
Scientific Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Shanghai Junshi biosciences
Ascletis Pharma
Merck and Co (MSD)
Pfizer
Shionogi
Market Analysis and Insights: Global Covid-19 Small Molecule Drugs Market
The global Covid-19 Small Molecule Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, RdRp accounting for % of the Covid-19 Small Molecule Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Covid-19 Small Molecule Drugs market size is valued at US$ million in 2021, while the North America and Europe Covid-19 Small Molecule Drugs are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Covid-19 Small Molecule Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Covid-19 Small Molecule Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Covid-19 Small Molecule Drugs market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Covid-19 Small Molecule Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Covid-19 Small Molecule Drugs market.
Global Covid-19 Small Molecule Drugs Scope and Market Size
Covid-19 Small Molecule Drugs market is segmented by players, region (country), by Targets and by Application. Players, stakeholders, and other participants in the global Covid-19 Small Molecule Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Targets and by Application for the period 2017-2028.
Segment by Targets
RdRp
3CLpro
Segment by Application
Hospital
Scientific Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Shanghai Junshi biosciences
Ascletis Pharma
Merck and Co (MSD)
Pfizer
Shionogi
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Targets
1.2.1 Global Covid-19 Small Molecule Drugs Market Size Growth Rate by Targets: 2017 VS 2021 VS 2028
1.2.2 RdRp
1.2.3 3CLpro
1.3 Market by Application
1.3.1 Global Covid-19 Small Molecule Drugs Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Scientific Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Covid-19 Small Molecule Drugs Market Perspective (2017-2028)
2.2 Covid-19 Small Molecule Drugs Growth Trends by Region
2.2.1 Covid-19 Small Molecule Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Covid-19 Small Molecule Drugs Historic Market Size by Region (2017-2022)
2.2.3 Covid-19 Small Molecule Drugs Forecasted Market Size by Region (2023-2028)
2.3 Covid-19 Small Molecule Drugs Market Dynamics
2.3.1 Covid-19 Small Molecule Drugs Industry Trends
2.3.2 Covid-19 Small Molecule Drugs Market Drivers
2.3.3 Covid-19 Small Molecule Drugs Market Challenges
2.3.4 Covid-19 Small Molecule Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Covid-19 Small Molecule Drugs Players by Revenue
3.1.1 Global Top Covid-19 Small Molecule Drugs Players by Revenue (2017-2022)
3.1.2 Global Covid-19 Small Molecule Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Covid-19 Small Molecule Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Covid-19 Small Molecule Drugs Revenue
3.4 Global Covid-19 Small Molecule Drugs Market Concentration Ratio
3.4.1 Global Covid-19 Small Molecule Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Small Molecule Drugs Revenue in 2021
3.5 Covid-19 Small Molecule Drugs Key Players Head office and Area Served
3.6 Key Players Covid-19 Small Molecule Drugs Product Solution and Service
3.7 Date of Enter into Covid-19 Small Molecule Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Small Molecule Drugs Breakdown Data by Targets
4.1 Global Covid-19 Small Molecule Drugs Historic Market Size by Targets (2017-2022)
4.2 Global Covid-19 Small Molecule Drugs Forecasted Market Size by Targets (2023-2028)
5 Covid-19 Small Molecule Drugs Breakdown Data by Application
5.1 Global Covid-19 Small Molecule Drugs Historic Market Size by Application (2017-2022)
5.2 Global Covid-19 Small Molecule Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Covid-19 Small Molecule Drugs Market Size (2017-2028)
6.2 North America Covid-19 Small Molecule Drugs Market Size by Country (2017-2022)
6.3 North America Covid-19 Small Molecule Drugs Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Covid-19 Small Molecule Drugs Market Size (2017-2028)
7.2 Europe Covid-19 Small Molecule Drugs Market Size by Country (2017-2022)
7.3 Europe Covid-19 Small Molecule Drugs Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Covid-19 Small Molecule Drugs Market Size (2017-2028)
8.2 Asia-Pacific Covid-19 Small Molecule Drugs Market Size by Country (2017-2022)
8.3 Asia-Pacific Covid-19 Small Molecule Drugs Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Covid-19 Small Molecule Drugs Market Size (2017-2028)
9.2 Latin America Covid-19 Small Molecule Drugs Market Size by Country (2017-2022)
9.3 Latin America Covid-19 Small Molecule Drugs Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Covid-19 Small Molecule Drugs Market Size (2017-2028)
10.2 Middle East & Africa Covid-19 Small Molecule Drugs Market Size by Country (2017-2022)
10.3 Middle East & Africa Covid-19 Small Molecule Drugs Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Shanghai Junshi biosciences
11.1.1 Shanghai Junshi biosciences Company Detail
11.1.2 Shanghai Junshi biosciences Business Overview
11.1.3 Shanghai Junshi biosciences Covid-19 Small Molecule Drugs Introduction
11.1.4 Shanghai Junshi biosciences Revenue in Covid-19 Small Molecule Drugs Business (2017-2022)
11.1.5 Shanghai Junshi biosciences Recent Development
11.2 Ascletis Pharma
11.2.1 Ascletis Pharma Company Detail
11.2.2 Ascletis Pharma Business Overview
11.2.3 Ascletis Pharma Covid-19 Small Molecule Drugs Introduction
11.2.4 Ascletis Pharma Revenue in Covid-19 Small Molecule Drugs Business (2017-2022)
11.2.5 Ascletis Pharma Recent Development
11.3 Merck and Co (MSD)
11.3.1 Merck and Co (MSD) Company Detail
11.3.2 Merck and Co (MSD) Business Overview
11.3.3 Merck and Co (MSD) Covid-19 Small Molecule Drugs Introduction
11.3.4 Merck and Co (MSD) Revenue in Covid-19 Small Molecule Drugs Business (2017-2022)
11.3.5 Merck and Co (MSD) Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Covid-19 Small Molecule Drugs Introduction
11.4.4 Pfizer Revenue in Covid-19 Small Molecule Drugs Business (2017-2022)
11.4.5 Pfizer Recent Development
11.5 Shionogi
11.5.1 Shionogi Company Detail
11.5.2 Shionogi Business Overview
11.5.3 Shionogi Covid-19 Small Molecule Drugs Introduction
11.5.4 Shionogi Revenue in Covid-19 Small Molecule Drugs Business (2017-2022)
11.5.5 Shionogi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Covid-19 Small Molecule Drugs Market Size Growth Rate by Targets (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of RdRp
Table 3. Key Players of 3CLpro
Table 4. Global Covid-19 Small Molecule Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Covid-19 Small Molecule Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Covid-19 Small Molecule Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Covid-19 Small Molecule Drugs Market Share by Region (2017-2022)
Table 8. Global Covid-19 Small Molecule Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Covid-19 Small Molecule Drugs Market Share by Region (2023-2028)
Table 10. Covid-19 Small Molecule Drugs Market Trends
Table 11. Covid-19 Small Molecule Drugs Market Drivers
Table 12. Covid-19 Small Molecule Drugs Market Challenges
Table 13. Covid-19 Small Molecule Drugs Market Restraints
Table 14. Global Covid-19 Small Molecule Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Covid-19 Small Molecule Drugs Market Share by Players (2017-2022)
Table 16. Global Top Covid-19 Small Molecule Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Small Molecule Drugs as of 2021)
Table 17. Ranking of Global Top Covid-19 Small Molecule Drugs Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Covid-19 Small Molecule Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Covid-19 Small Molecule Drugs Product Solution and Service
Table 21. Date of Enter into Covid-19 Small Molecule Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Covid-19 Small Molecule Drugs Market Size by Targets (2017-2022) & (US$ Million)
Table 24. Global Covid-19 Small Molecule Drugs Revenue Market Share by Targets (2017-2022)
Table 25. Global Covid-19 Small Molecule Drugs Forecasted Market Size by Targets (2023-2028) & (US$ Million)
Table 26. Global Covid-19 Small Molecule Drugs Revenue Market Share by Targets (2023-2028)
Table 27. Global Covid-19 Small Molecule Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Covid-19 Small Molecule Drugs Revenue Market Share by Application (2017-2022)
Table 29. Global Covid-19 Small Molecule Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Covid-19 Small Molecule Drugs Revenue Market Share by Application (2023-2028)
Table 31. North America Covid-19 Small Molecule Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Covid-19 Small Molecule Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Covid-19 Small Molecule Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Covid-19 Small Molecule Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Covid-19 Small Molecule Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Covid-19 Small Molecule Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Covid-19 Small Molecule Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Covid-19 Small Molecule Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Covid-19 Small Molecule Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Covid-19 Small Molecule Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 41. Shanghai Junshi biosciences Company Detail
Table 42. Shanghai Junshi biosciences Business Overview
Table 43. Shanghai Junshi biosciences Covid-19 Small Molecule Drugs Product
Table 44. Shanghai Junshi biosciences Revenue in Covid-19 Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 45. Shanghai Junshi biosciences Recent Development
Table 46. Ascletis Pharma Company Detail
Table 47. Ascletis Pharma Business Overview
Table 48. Ascletis Pharma Covid-19 Small Molecule Drugs Product
Table 49. Ascletis Pharma Revenue in Covid-19 Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 50. Ascletis Pharma Recent Development
Table 51. Merck and Co (MSD) Company Detail
Table 52. Merck and Co (MSD) Business Overview
Table 53. Merck and Co (MSD) Covid-19 Small Molecule Drugs Product
Table 54. Merck and Co (MSD) Revenue in Covid-19 Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 55. Merck and Co (MSD) Recent Development
Table 56. Pfizer Company Detail
Table 57. Pfizer Business Overview
Table 58. Pfizer Covid-19 Small Molecule Drugs Product
Table 59. Pfizer Revenue in Covid-19 Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. Shionogi Company Detail
Table 62. Shionogi Business Overview
Table 63. Shionogi Covid-19 Small Molecule Drugs Product
Table 64. Shionogi Revenue in Covid-19 Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 65. Shionogi Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Covid-19 Small Molecule Drugs Market Share by Targets: 2021 VS 2028
Figure 2. RdRp Features
Figure 3. 3CLpro Features
Figure 4. Global Covid-19 Small Molecule Drugs Market Share by Application in 2021 & 2028
Figure 5. Hospital Case Studies
Figure 6. Scientific Research Case Studies
Figure 7. Covid-19 Small Molecule Drugs Report Years Considered
Figure 8. Global Covid-19 Small Molecule Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Covid-19 Small Molecule Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Covid-19 Small Molecule Drugs Market Share by Region: 2021 VS 2028
Figure 11. Global Covid-19 Small Molecule Drugs Market Share by Players in 2021
Figure 12. Global Top Covid-19 Small Molecule Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Small Molecule Drugs as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Covid-19 Small Molecule Drugs Revenue in 2021
Figure 14. North America Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 15. North America Covid-19 Small Molecule Drugs Market Share by Country (2017-2028)
Figure 16. United States Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. Canada Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Europe Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Covid-19 Small Molecule Drugs Market Share by Country (2017-2028)
Figure 20. Germany Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. France Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. U.K. Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Italy Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Russia Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Nordic Countries Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Covid-19 Small Molecule Drugs Market Share by Region (2017-2028)
Figure 28. China Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Japan Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. South Korea Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Southeast Asia Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. India Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Australia Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Latin America Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Covid-19 Small Molecule Drugs Market Share by Country (2017-2028)
Figure 36. Mexico Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Brazil Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Middle East & Africa Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Covid-19 Small Molecule Drugs Market Share by Country (2017-2028)
Figure 40. Turkey Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Saudi Arabia Covid-19 Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Shanghai Junshi biosciences Revenue Growth Rate in Covid-19 Small Molecule Drugs Business (2017-2022)
Figure 43. Ascletis Pharma Revenue Growth Rate in Covid-19 Small Molecule Drugs Business (2017-2022)
Figure 44. Merck and Co (MSD) Revenue Growth Rate in Covid-19 Small Molecule Drugs Business (2017-2022)
Figure 45. Pfizer Revenue Growth Rate in Covid-19 Small Molecule Drugs Business (2017-2022)
Figure 46. Shionogi Revenue Growth Rate in Covid-19 Small Molecule Drugs Business (2017-2022)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
